This is a preview of subscription content, log in via an institution to check access.
References
Park KU, Bazan JG. Implications of omitting sentinel lymph node biopsy in patients older than 70 years. JAMA Surg. 2021;156(2):199–200. https://doi.org/10.1001/jamasurg.2020.5008.
Wang T, Baskin AS, Dossett LA. Deimplementation of the choosing wisely recommendations for low-value breast cancer surgery: a systematic review. JAMA Surg. 2020;155(8):759–70. https://doi.org/10.1001/jamasurg.2020.0322.
Mukhtar RA, Brabham CE, Guo R, et al. Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast: factors associated with false negatives. Breast J. 2021;27(4):406–8. https://doi.org/10.1111/tbj.14161.
Carleton N, Zou J, Fang Y, et al. Outcomes After sentinel lymph node biopsy and radiotherapy in older women with early-stage, estrogen receptor-positive breast cancer. JAMA Netw Open. 2021;4(4):e216322. https://doi.org/10.1001/jamanetworkopen.2021.6322.
Giobbie-Hurder A, Gelber RD, Regan MM. Challenges of guarantee-time bias. J Clin Oncol. 2013;31(23):2963–9. https://doi.org/10.1200/jco.2013.49.5283.
Chung A, Gangi A, Amersi F, Zhang X, Giuliano A. Not performing a sentinel node biopsy for older patients with early-stage invasive breast cancer. JAMA Surg. 2015;150(7):683–4. https://doi.org/10.1001/jamasurg.2015.0647.
Acknowledgment
The authors acknowledge the many contributions of the patients, families, researchers, clinical staff, and sponsors of this study. The authors of this study thank the members of the Lee–Oesterreich lab for their helpful discussions and support. The Department of Clinical Analytics in the UPMC Health Services Division generated the raw data for this analysis with the support of the UPMC Network Cancer Registry.
Funding
Shear Family Foundation (to Adrian V. Lee & Steffi Oesterreich), National Cancer Institute under Award Number 1F30CA264963-01 (to Neil Carleton), and a UPMC Hillman Cancer Center Developmental Pilot Grant (to Adrian V. Lee & Steffi Oesterreich). Steffi Oesterreich and Adrian Lee are also funded by the Breast Cancer Research Foundation and are Komen Scholars. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Contributions
Concept and Design: PFM; Acquisition, Analysis, or Interpretation of the Data: NC, PFM, EJD, AVL, OCM; Drafting the Manuscript: NC, PFM, AVL, SO; Critical Revision of the Manuscript: NC, SO, AVL, PFM, EJD, GT, OCM; Statistical Analysis: NC, PFM, GT; Obtained Funding: AVL, SO, NC; Administrative, Technical, or Material Support: AVL, SO, EJD, OCM; Supervision: AVL, PFM, SO, EJD; Adrian V. Lee, PhD, and Priscilla F. McAuliffe, MD, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Corresponding author
Ethics declarations
Disclosures
The authors have no conflicts of interest or other items to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Carleton, N., Oesterreich, S., Marroquin, O.C. et al. Is the Choosing Wisely Recommendation for Omission of Sentinel Lymph Node Biopsy Applicable for Invasive Lobular Carcinoma?. Ann Surg Oncol 29, 5379–5382 (2022). https://doi.org/10.1245/s10434-022-12003-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12003-3